Unique ID issued by UMIN | UMIN000009408 |
---|---|
Receipt number | R000011055 |
Scientific Title | Effectiveness research of Q'sai "Aojiru", against metabolic syndrome. |
Date of disclosure of the study information | 2012/12/01 |
Last modified on | 2013/11/27 09:11:51 |
Effectiveness research of Q'sai "Aojiru", against metabolic syndrome.
Intake effect of Q'sai "Aojiru"
Effectiveness research of Q'sai "Aojiru", against metabolic syndrome.
Intake effect of Q'sai "Aojiru"
Japan |
Metabolic Syndrome
Not applicable |
Others
NO
To evaluate effects of consumption of Q'sai Kale-based "Aojiru" against metabolic syndrome. To find effective intake and improved indicators from viewpoints of disease prevention and treatment assistance.
Efficacy
Exploratory
Pragmatic
Not applicable
Blood pressure
Neutral fat, LDL Cholesterol, HDL cholesterol,
Fasting Blood Sugar, HbA1c,
Body Mass Index, Waist,
Evaluated at the time of registration, intake start and end in 8 week.
Questionnaire on feeling effectiveness.
Evaluated at the time of registration, at the time of an intake start and end in 8 week.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Intake of "Aojiru"
30 | years-old | <= |
75 | years-old | > |
Male and Female
1) Habitants who took a medical check in Arita
2) Person who are age from 30 to 74.
3) Person who correspond to the following at least one items.
1.Waist Male >= 85cm Female>=90cm
2.Fasting triglyceride >= 150mg/dL and/or HDL Cholesterol < 40mg/dL
3. SBP >= 120mmHg and/or DBP >= 80mmHg
4.Fasting Blood Sugar >= 110mg/dL
5. BMI >= 25kg/m2
6.LDL Cholesterol>=120mg/dL
4) Person who can consume the product continuously.
1) Person who takes regularly health care products including Q'sai "Aojiru" and other products .
2) Person whose latest clinical laboratory test results are significantly out of standard value and an investigator determined that he/she is required to take treatment.
3) Person who get an atrial fibrillation
4) Person who has critical disease history such as cardiac disease, cerebrovascular disease, kidney disease
5) Person who take warfarin potassium
6) Person who has allergies to plants of the Brassicaceae, including Kale.
7) Person who participated another clinical investigation or trial within 2 months from the start date of this study.
8) With other factors, an investigator determines that a person is unfit to participate the study.
60
1st name | |
Middle name | |
Last name | Tomomi Ide |
Kyushu University
Department of Cardiovascular medicine Kyushu University Graduate School of Medical Sciences
3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
092-642-5371
1st name | |
Middle name | |
Last name | Hisami Inuduka |
Hubit genomix, Inc.
Business Promotion Unit
79-5 Toshakuhei, Arita-cho Nishimatsuura-gun, Saga 844-0017, Japan
0955-43-3334
hinuzuka@hubitgenomix.com
Q'SAI CO,Ltd.
None
Self funding
Japan
NO
有田町 健康福祉課(佐賀県)
2012 | Year | 12 | Month | 01 | Day |
Unpublished
Completed
2012 | Year | 11 | Month | 06 | Day |
2013 | Year | 01 | Month | 17 | Day |
2013 | Year | 05 | Month | 17 | Day |
2013 | Year | 06 | Month | 01 | Day |
2013 | Year | 06 | Month | 14 | Day |
2013 | Year | 08 | Month | 31 | Day |
2012 | Year | 11 | Month | 27 | Day |
2013 | Year | 11 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011055
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |